Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins?
The inhibition of cellular proliferation, the restoration of endothelial activity, the inhibition of platelet reactivity, and an antioxidant potential are only a few examples of pleiotropic effects of statins. This review analyzes the current knowledge on the pleiotropic properties of this class of...
Gespeichert in:
| Veröffentlicht in: | Current atherosclerosis reports 2000, Vol.2 (1), p.20-25 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 25 |
|---|---|
| container_issue | 1 |
| container_start_page | 20 |
| container_title | Current atherosclerosis reports |
| container_volume | 2 |
| creator | Faggiotto, A Paoletti, R |
| description | The inhibition of cellular proliferation, the restoration of endothelial activity, the inhibition of platelet reactivity, and an antioxidant potential are only a few examples of pleiotropic effects of statins. This review analyzes the current knowledge on the pleiotropic properties of this class of drugs and examines the relevant data that support the presence of these effects in vivo. The favorable outcome of major trials of statins has indicated that pleiotropic factors indeed play a role in cardiovascular protection. In addition, recent data indicate that many pleiotropic effects influence mechanisms that belong to the extravascular compartment, as well. Perhaps, some of these properties may eventually justify additional indications for statins and improve the treatment of other diseases, including inflammation and cancer. |
| doi_str_mv | 10.1007/s11883-000-0091-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72525657</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72525657</sourcerecordid><originalsourceid>FETCH-LOGICAL-c212t-7aef722221b9641b00796c0f125265c58d7e76b4426394e58776bfafff959c93</originalsourceid><addsrcrecordid>eNpFkE1LxDAQhoMoun78AC-Sk7dqJmmb9iSyfsKCF8FjSNsJG-k2Ncnuuif_ull2xUDITDLvA3kIuQR2A4zJ2wBQVSJjjKVdQyYOyAQKkWclz_nhtuYiExXLT8hpCJ-McVaVcExOAIBzyWFCfh4cHXu0Lno32paiMdjGQJ2hIepoh0Ab3Liho70dbUd1H9Gne5ce8NuGSO1AV3bl7ujHXEeqPdI4xw3VKTJ3a9q5Xd_ZRPYJFteIwx_87pwcGd0HvNifZ-T96fF9-pLN3p5fp_ezrOXAYyY1GsnTgqYuc2jS7-uyZQZ4wcuiLapOoiybPOelqHMsKpk6o40xdVG3tTgj1zvs6N3XEkNUCxta7Hs9oFsGJROnKAuZBmE32HoXgkejRm8X2m8UMLWVrnbSVZKuttKVSJmrPXzZLLD7T-wti19ZYn3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72525657</pqid></control><display><type>article</type><title>Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins?</title><source>MEDLINE</source><source>SpringerNature Complete Journals</source><creator>Faggiotto, A ; Paoletti, R</creator><creatorcontrib>Faggiotto, A ; Paoletti, R</creatorcontrib><description>The inhibition of cellular proliferation, the restoration of endothelial activity, the inhibition of platelet reactivity, and an antioxidant potential are only a few examples of pleiotropic effects of statins. This review analyzes the current knowledge on the pleiotropic properties of this class of drugs and examines the relevant data that support the presence of these effects in vivo. The favorable outcome of major trials of statins has indicated that pleiotropic factors indeed play a role in cardiovascular protection. In addition, recent data indicate that many pleiotropic effects influence mechanisms that belong to the extravascular compartment, as well. Perhaps, some of these properties may eventually justify additional indications for statins and improve the treatment of other diseases, including inflammation and cancer.</description><identifier>ISSN: 1523-3804</identifier><identifier>EISSN: 1534-6242</identifier><identifier>DOI: 10.1007/s11883-000-0091-3</identifier><identifier>PMID: 11122721</identifier><language>eng</language><publisher>United States</publisher><subject>Anticholesteremic Agents - pharmacology ; Antioxidants - pharmacology ; Arteriosclerosis - prevention & control ; Blood Platelets - physiology ; Endothelium - physiology ; Humans ; Inflammation ; Lipid Metabolism</subject><ispartof>Current atherosclerosis reports, 2000, Vol.2 (1), p.20-25</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c212t-7aef722221b9641b00796c0f125265c58d7e76b4426394e58776bfafff959c93</citedby><cites>FETCH-LOGICAL-c212t-7aef722221b9641b00796c0f125265c58d7e76b4426394e58776bfafff959c93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11122721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Faggiotto, A</creatorcontrib><creatorcontrib>Paoletti, R</creatorcontrib><title>Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins?</title><title>Current atherosclerosis reports</title><addtitle>Curr Atheroscler Rep</addtitle><description>The inhibition of cellular proliferation, the restoration of endothelial activity, the inhibition of platelet reactivity, and an antioxidant potential are only a few examples of pleiotropic effects of statins. This review analyzes the current knowledge on the pleiotropic properties of this class of drugs and examines the relevant data that support the presence of these effects in vivo. The favorable outcome of major trials of statins has indicated that pleiotropic factors indeed play a role in cardiovascular protection. In addition, recent data indicate that many pleiotropic effects influence mechanisms that belong to the extravascular compartment, as well. Perhaps, some of these properties may eventually justify additional indications for statins and improve the treatment of other diseases, including inflammation and cancer.</description><subject>Anticholesteremic Agents - pharmacology</subject><subject>Antioxidants - pharmacology</subject><subject>Arteriosclerosis - prevention & control</subject><subject>Blood Platelets - physiology</subject><subject>Endothelium - physiology</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Lipid Metabolism</subject><issn>1523-3804</issn><issn>1534-6242</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LxDAQhoMoun78AC-Sk7dqJmmb9iSyfsKCF8FjSNsJG-k2Ncnuuif_ull2xUDITDLvA3kIuQR2A4zJ2wBQVSJjjKVdQyYOyAQKkWclz_nhtuYiExXLT8hpCJ-McVaVcExOAIBzyWFCfh4cHXu0Lno32paiMdjGQJ2hIepoh0Ab3Liho70dbUd1H9Gne5ce8NuGSO1AV3bl7ujHXEeqPdI4xw3VKTJ3a9q5Xd_ZRPYJFteIwx_87pwcGd0HvNifZ-T96fF9-pLN3p5fp_ezrOXAYyY1GsnTgqYuc2jS7-uyZQZ4wcuiLapOoiybPOelqHMsKpk6o40xdVG3tTgj1zvs6N3XEkNUCxta7Hs9oFsGJROnKAuZBmE32HoXgkejRm8X2m8UMLWVrnbSVZKuttKVSJmrPXzZLLD7T-wti19ZYn3A</recordid><startdate>2000</startdate><enddate>2000</enddate><creator>Faggiotto, A</creator><creator>Paoletti, R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2000</creationdate><title>Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins?</title><author>Faggiotto, A ; Paoletti, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c212t-7aef722221b9641b00796c0f125265c58d7e76b4426394e58776bfafff959c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anticholesteremic Agents - pharmacology</topic><topic>Antioxidants - pharmacology</topic><topic>Arteriosclerosis - prevention & control</topic><topic>Blood Platelets - physiology</topic><topic>Endothelium - physiology</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Lipid Metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Faggiotto, A</creatorcontrib><creatorcontrib>Paoletti, R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current atherosclerosis reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Faggiotto, A</au><au>Paoletti, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins?</atitle><jtitle>Current atherosclerosis reports</jtitle><addtitle>Curr Atheroscler Rep</addtitle><date>2000</date><risdate>2000</risdate><volume>2</volume><issue>1</issue><spage>20</spage><epage>25</epage><pages>20-25</pages><issn>1523-3804</issn><eissn>1534-6242</eissn><abstract>The inhibition of cellular proliferation, the restoration of endothelial activity, the inhibition of platelet reactivity, and an antioxidant potential are only a few examples of pleiotropic effects of statins. This review analyzes the current knowledge on the pleiotropic properties of this class of drugs and examines the relevant data that support the presence of these effects in vivo. The favorable outcome of major trials of statins has indicated that pleiotropic factors indeed play a role in cardiovascular protection. In addition, recent data indicate that many pleiotropic effects influence mechanisms that belong to the extravascular compartment, as well. Perhaps, some of these properties may eventually justify additional indications for statins and improve the treatment of other diseases, including inflammation and cancer.</abstract><cop>United States</cop><pmid>11122721</pmid><doi>10.1007/s11883-000-0091-3</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1523-3804 |
| ispartof | Current atherosclerosis reports, 2000, Vol.2 (1), p.20-25 |
| issn | 1523-3804 1534-6242 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72525657 |
| source | MEDLINE; SpringerNature Complete Journals |
| subjects | Anticholesteremic Agents - pharmacology Antioxidants - pharmacology Arteriosclerosis - prevention & control Blood Platelets - physiology Endothelium - physiology Humans Inflammation Lipid Metabolism |
| title | Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T13%3A20%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Do%20pleiotropic%20effects%20of%20statins%20beyond%20lipid%20alterations%20exist%20in%20vivo?%20What%20are%20they%20and%20how%20do%20they%20differ%20between%20statins?&rft.jtitle=Current%20atherosclerosis%20reports&rft.au=Faggiotto,%20A&rft.date=2000&rft.volume=2&rft.issue=1&rft.spage=20&rft.epage=25&rft.pages=20-25&rft.issn=1523-3804&rft.eissn=1534-6242&rft_id=info:doi/10.1007/s11883-000-0091-3&rft_dat=%3Cproquest_cross%3E72525657%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72525657&rft_id=info:pmid/11122721&rfr_iscdi=true |